C
Clairity
AI/ML company focused on shifting the value of medical imaging from pure diagnosis to prediction and prevention
About Clairity
Clairity is a startup that operates in the healthcare technology sector, specifically focusing on the application of artificial intelligence (AI) in the field of radiomics and population health. The company's primary service is the development of AI solutions that are designed to improve the accuracy of breast cancer risk models. These models are based on deep learning techniques, a subset of AI that mimics the human brain's learning process, which have been shown to outperform traditional risk models.
The company's approach to AI solution development is rigorous and evidence-based, grounded in decades of research conducted by Dr. Connie Lehman at leading academic medical centers. This research has been conducted at renowned institutions such as MassGeneral Brigham, MIT, and the University of Washington.
Clairity's target clients are primarily healthcare providers and institutions that require advanced diagnostic tools for breast cancer. The company operates in the healthcare technology market, which is a rapidly growing sector due to the increasing demand for more efficient and accurate diagnostic tools.
The business model of Clairity is likely based on a B2B (Business to Business) model, where they sell their AI solutions to healthcare providers and institutions. The company generates revenue by selling these AI solutions, which are designed to improve the accuracy and efficiency of breast cancer diagnosis.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Boston, United States
- Employees
- 15
- Open positions
- 1
- Dealroom signal
- 78.8/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Oncology, Radiology, Core AI, AI for medical imaging, Hard Tech, AI Applications, Preventive Care
- Technology
- Artificial Intelligence, Deep Tech, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Nov 2025 | $43M | $172M | Sante Ventures | ↗ |
| GRANTOther financing | Jan 2025 | $1M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Clairity is 5.1K monthly website visits, down 40% over the last three months. Clairity's team declined 11.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Sante Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Clairity on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Clairity’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.